Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Autoantibody profiling for lung cancer screening longitudinal retrospective analysis of CT screening cohorts.

Trudgen K, Khattar NH, Bensadoun E, Arnold S, Stromberg AJ, Hirschowitz EA.

PLoS One. 2014 Feb 3;9(2):e87947. doi: 10.1371/journal.pone.0087947. eCollection 2014.

2.

Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.

Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA.

J Thorac Oncol. 2006 Jul;1(6):513-9.

3.

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.

Sestini S, Boeri M, Marchiano A, Pelosi G, Galeone C, Verri C, Suatoni P, Sverzellati N, La Vecchia C, Sozzi G, Pastorino U.

Oncotarget. 2015 Oct 20;6(32):32868-77. doi: 10.18632/oncotarget.5210.

4.

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JW, Nackaerts K, Vliegenthart R, ten Haaf K, Yousaf-Khan UA, Heuvelmans MA, Thunnissen E, Oudkerk M, Mali W, de Koning HJ.

Lancet Oncol. 2014 Nov;15(12):1342-50. doi: 10.1016/S1470-2045(14)70387-0. Epub 2014 Oct 1.

PMID:
25282284
5.

Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers.

Hazelton WD, Goodman G, Rom WN, Tockman M, Thornquist M, Moolgavkar S, Weissfeld JL, Feng Z.

Math Biosci. 2012 Nov;240(1):20-34. doi: 10.1016/j.mbs.2012.05.008. Epub 2012 Jun 15.

6.

Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.

Wang J, Shivakumar S, Barker K, Tang Y, Wallstrom G, Park JG, Tsay JC, Pass HI, Rom WN, LaBaer J, Qiu J.

J Thorac Oncol. 2016 Mar;11(3):334-45. doi: 10.1016/j.jtho.2015.11.011. Epub 2016 Feb 16.

7.

Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.

Menezes RJ, Roberts HC, Paul NS, McGregor M, Chung TB, Patsios D, Weisbrod G, Herman S, Pereira A, McGregor A, Dong Z, Sitartchouk I, Boerner S, Tsao MS, Keshavjee S, Shepherd FA.

Lung Cancer. 2010 Feb;67(2):177-83. doi: 10.1016/j.lungcan.2009.03.030. Epub 2009 May 7.

PMID:
19427055
8.

Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer.

Khattar NH, Coe-Atkinson SP, Stromberg AJ, Jett JR, Hirschowitz EA.

Cancer Biol Ther. 2010 Aug 1;10(3):267-72. Epub 2010 Aug 18.

9.

Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.

Karabudak AA, Hafner J, Shetty V, Chen S, Secord AA, Morse MA, Philip R.

J Cancer Res Clin Oncol. 2013 Oct;139(10):1757-70. doi: 10.1007/s00432-013-1501-6. Epub 2013 Sep 3.

10.

A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening.

Bigbee WL, Gopalakrishnan V, Weissfeld JL, Wilson DO, Dacic S, Lokshin AE, Siegfried JM.

J Thorac Oncol. 2012 Apr;7(4):698-708. doi: 10.1097/JTO.0b013e31824ab6b0.

11.

Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.

Carozzi FM, Bisanzi S, Carrozzi L, Falaschi F, Lopes Pegna A, Mascalchi M, Picozzi G, Peluso M, Sani C, Greco L, Ocello C, Paci E; ITALUNG Working Group.

Int J Cancer. 2017 Jul 1;141(1):94-101. doi: 10.1002/ijc.30727. Epub 2017 Apr 21.

PMID:
28387927
12.

EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.

Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, Chapman CJ, Allen J, Wood WC, Sewell HF, Robertson JF.

Cancer Prev Res (Phila). 2011 Jul;4(7):1126-34. doi: 10.1158/1940-6207.CAPR-10-0328.

13.

Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.

Doseeva V, Colpitts T, Gao G, Woodcock J, Knezevic V.

J Transl Med. 2015 Feb 12;13:55. doi: 10.1186/s12967-015-0419-y.

14.

Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum.

Kilic A, Schuchert MJ, Luketich JD, Landreneau RJ, Lokshin AE, Bigbee WL, El-Hefnawy T.

J Thorac Cardiovasc Surg. 2008 Jul;136(1):199-204. doi: 10.1016/j.jtcvs.2008.01.012. Epub 2008 May 22.

15.

Lung cancer screening--comparison of computed tomography and X-ray.

Fujikawa A, Takiguchi Y, Mizuno S, Uruma T, Suzuki K, Nagao K, Niijima M, Edo H, Hino M, Kuriyama T.

Lung Cancer. 2008 Aug;61(2):195-201. doi: 10.1016/j.lungcan.2007.12.010. Epub 2008 Feb 1.

PMID:
18242764
16.

Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.

Veronesi G, Bellomi M, Mulshine JL, Pelosi G, Scanagatta P, Paganelli G, Maisonneuve P, Preda L, Leo F, Bertolotti R, Solli P, Spaggiari L.

Lung Cancer. 2008 Sep;61(3):340-9. doi: 10.1016/j.lungcan.2008.01.001. Epub 2008 Mar 4.

PMID:
18308420
18.

PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.

Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roqué I Figuls M.

Cochrane Database Syst Rev. 2014 Nov 13;(11):CD009519. doi: 10.1002/14651858.CD009519.pub2. Review.

PMID:
25393718
19.

Automated 3-dimensional morphologic analysis of sputum specimens for lung cancer detection: Performance characteristics support use in lung cancer screening.

Wilbur DC, Meyer MG, Presley C, Aye RW, Zarogoulidis P, Johnson DW, Peled N, Nelson AC.

Cancer Cytopathol. 2015 Sep;123(9):548-56. doi: 10.1002/cncy.21565. Epub 2015 Jul 6.

20.

Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers.

Hulbert A, Hooker CM, Keruly JC, Brown T, Horton K, Fishman E, Rodgers K, Lee B, Sam C, Tsai S, Weihe E, Pridham G, Drummond B, Merlo C, Geronimo M, Porter M, Cox S, Li D, Harline M, Teran M, Wrangle J, Mudge B, Taylor G, Kirk GD, Herman JG, Moore RD, Brown RH, Brock MV.

J Thorac Oncol. 2014 Jun;9(6):752-9. doi: 10.1097/JTO.0000000000000161.

Supplemental Content

Support Center